We are live on ! Find out more
CNLM

CB PHARMA ACQUISISTION CORP SHS (CYM)
CNLM

Delisted

CNLM was delisted on the 8th of June, 2016.

Back to rankings

6 hedge funds and large institutions have $11.9M invested in CB PHARMA ACQUISISTION CORP SHS (CYM) in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 6 → 6 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

20% less capital invested

Capital invested by funds: $14.8M → $11.9M (-$2.88M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
YCM
Yakira Capital Management
Connecticut
+$123K

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$1.95M
2
KIM
Karpus Investment Management
New York
-$1.17M
3
TRCT
Tower Research Capital (TRC)
New York
-$10
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$5.43M – – –
AA
2
AQR Arbitrage
Connecticut
$3.46M – – –
WAM
3
Weiss Asset Management
Massachusetts
$2.65M – – –
GCL
4
Glazer Capital LLC
New York
$230K -$1.95M -198,436 -90%
YCM
5
Yakira Capital Management
Connecticut
$124K +$123K +12,500 New
KIM
6
Karpus Investment Management
New York
– -$1.17M -119,600 Closed
TRCT
7
Tower Research Capital (TRC)
New York
– -$10 -1 -5%

CNLM Hedge Fund Activity: Q2 2015 in Review

6 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) for Q2 2015, worth a combined $11.9M — down 20% from $14.8M a quarter earlier.

Fund positioning in CNLM was balanced in Q2 2015: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 2 trimmed.

The largest buyer was Yakira Capital Management, opening a new position worth an estimated $123K. The largest seller was Glazer Capital LLC, cutting an estimated $1.95M.

  • 6 institutional investors held CB PHARMA ACQUISISTION CORP SHS (CYM) (CNLM) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $11.9M of CB PHARMA ACQUISISTION CORP SHS (CYM) stock for Q2 2015, down 20% quarter-over-quarter.
  • 1 fund opened new CB PHARMA ACQUISISTION CORP SHS (CYM) positions in Q2 2015 and 1 closed out, a net change of 0 holders.
  • The largest CB PHARMA ACQUISISTION CORP SHS (CYM) buyer in Q2 2015 was Yakira Capital Management, an estimated $123K added.
  • The largest CB PHARMA ACQUISISTION CORP SHS (CYM) seller in Q2 2015 was Glazer Capital LLC, an estimated $1.95M sold.

Based on aggregated 13F filings for Q2 2015.